Unichem Lab Shares Surge Further By 4.5 Per cent

Posted By: Staff
Subscribe to GoodReturns

Mumbai, Mar 10 (PTI) Shares of Unichem Laboratories further surged by 4.5 per cent today following the USFDA nod for generic Quetiapine Fumarate tablets used for the treatment of schizophrenia and bipolar disorder.

Extending its previous session's rally, the stock rose by 4.5 per cent to Rs 241.40 on BSE. On NSE, it gained 4.51 per cent to Rs 242.

Unichem Lab Shares Surge Further By 4.5 Per cent
Unichem Laboratories: Quotes, News
BSE 363.75BSE Quote2.75 (0.76%)
NSE 363.50NSE Quote2.15 (0.59%)

In the previous session also the stock had soared up to 3.5 per cent. "The company has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA) for Quetiapine Fumarate tablets," Unichem Laboratories had said in a BSE filing yesterday.

The approval is for the company's tablets in strengths of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg, it added.

"The product will be commercialised from Unichem's Ghaziabad plant. Active Pharmaceutical Ingredient will also be made in house at Pithampur API plant," the company had said.


Read more about: unichem laboratories
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


Get Latest News alerts from Goodreturns